65 related articles for article (PubMed ID: 38566539)
1. Prevalence and genotype distribution of human papillomavirus infection among female outpatients in Northeast China: a population-based survey of 110,927 women.
Zhang H; Zhang S
Arch Gynecol Obstet; 2023 Jul; 308(1):35-41. PubMed ID: 35904609
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
Poljak M; Seme K; Maver PJ; Kocjan BJ; Cuschieri KS; Rogovskaya SI; Arbyn M; Syrjänen S
Vaccine; 2013 Dec; 31 Suppl 7():H59-70. PubMed ID: 24332298
[TBL] [Abstract][Full Text] [Related]
3. High burden of human papillomavirus infection among men in Guangzhou, South China: Implications for HPV vaccination strategies.
Liu P; Yang X; Zhao H; Liang L; Chen M; Yin A
Hum Vaccin Immunother; 2024 Dec; 20(1):2337161. PubMed ID: 38566539
[TBL] [Abstract][Full Text] [Related]
4. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China.
Wang R; Guo XL; Wisman GB; Schuuring E; Wang WF; Zeng ZY; Zhu H; Wu SW
BMC Infect Dis; 2015 Jul; 15():257. PubMed ID: 26142044
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus genotypic characteristics of 60,685 subjects under age-expansion vaccination of the nine-valent human papillomavirus vaccine: A cross-sectional study.
Liu Y; Li Z; Yuan L; Liu F; Wu K; Xiao X; Zhu C
J Infect Public Health; 2023 Jul; 16(7):989-995. PubMed ID: 37167646
[TBL] [Abstract][Full Text] [Related]
6. HPV genotypic spectrum in Jilin province, China, where non-vaccine-covered HPV53 and 51 are prevalent, exhibits a bimodal age-specific pattern.
Hao S; Wang C; Liu S; He J; Jiang Y
PLoS One; 2020; 15(3):e0230640. PubMed ID: 32208459
[TBL] [Abstract][Full Text] [Related]
7. HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory.
Jiang L; Tian X; Peng D; Zhang L; Xie F; Bi C; Wang R; Wang J; Qi D
PLoS One; 2019; 14(1):e0210311. PubMed ID: 30653566
[TBL] [Abstract][Full Text] [Related]
8. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis.
Bruni L; Albero G; Rowley J; Alemany L; Arbyn M; Giuliano AR; Markowitz LE; Broutet N; Taylor M
Lancet Glob Health; 2023 Sep; 11(9):e1345-e1362. PubMed ID: 37591583
[TBL] [Abstract][Full Text] [Related]
9. Gender neutral HPV vaccination programs: Reconsidering policies to expand cancer prevention globally.
Dykens JA; Peterson CE; Holt HK; Harper DM
Front Public Health; 2023; 11():1067299. PubMed ID: 36895694
[TBL] [Abstract][Full Text] [Related]
10. Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021.
Yang X; Li Y; Tang Y; Li Z; Wang S; Luo X; He T; Yin A; Luo M
Emerg Microbes Infect; 2023 Dec; 12(1):e2176009. PubMed ID: 36744409
[TBL] [Abstract][Full Text] [Related]
11. Chlamydia trachomatis infection co-operatively enhances HPV E6-E7 oncogenes mediated tumorigenesis and immunosuppression.
Challagundla N; Chrisophe-Bourdon J; Agrawal-Rajput R
Microb Pathog; 2023 Feb; 175():105929. PubMed ID: 36565970
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus vaccination and cervical cancer risk.
Rahangdale L; Mungo C; O'Connor S; Chibwesha CJ; Brewer NT
BMJ; 2022 Dec; 379():e070115. PubMed ID: 36521855
[TBL] [Abstract][Full Text] [Related]
13. Status quo and problem analysis of cervical cancer screening program in China: Based on RE-AIM framework.
Zhu J; Ge Z; Xia J; Liu Q; Ran Q; Yang Y
Front Public Health; 2022; 10():987787. PubMed ID: 36311598
[TBL] [Abstract][Full Text] [Related]
14. Willingness to human papillomavirus (HPV) vaccination and influencing factors among male and female university students in China.
Dai Z; Si M; Su X; Wang W; Zhang X; Gu X; Ma L; Li J; Zhang S; Ren Z; Qiao Y
J Med Virol; 2022 Jun; 94(6):2776-2786. PubMed ID: 34825712
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
